Below is a list of the top 25 pharmaceutical companies by market capitalization at the end of December 2018, according to Endpoint News.
The list doesn’t include Johnson & Johnson, which has a market cap of $371 billion, because it is not a “pure play pharma giant” with its many business units, according to the report.
The top 25 pharma players, as of December 2018:
1. Pfizer — $253.2 billion
2. Roche — $212.5 billion
3. Merck & Co. — $198.7 billion
4. Novartis — $195.4 billion
5. AbbVie — $139.6 billion
6. Abbott Laboratories — $127 billion
7. Amgen — $124 billion
8. Eli Lilly — $122.6 billion
9. Novo Nordisk — $112.9 billion
10. Sanofi — $111.3 billion
11. AstraZeneca — $99.2 billion
12. GlaxoSmithKline — $98.2 billion
13. Bristol-Myers Squibb — $84.8 billion
14. Gilead Sciences — $80.9 billion
15. Bayer — $66.6 billion
16. CSL — $62.5 billion
17. Biogen — $60.6 billion
18. Merck KGaA — $46.2 billion
19. Allergan — $45.1 billion
20. Celgene — $44.8 billion
21. Vertex Pharmaceuticals — $42.3 billion
22. Shire — $42 billion
23. Regeneron Pharmaceuticals — $40.4 billion
24. Chugai Pharmaceuticals — $31.5 billion
25. Jiangsu Hengrui Medicine Co. — $29.4 billion
More articles on pharmacy:
10 hospitals seeking pharmacy leaders
Walgreens shaking up C-suite
Generic drugmakers could thrive in a recession, Moody’s says
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
